Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate bills "do not go far enough" in allowing FDA to assure safety and efficacy of imported drugs, FDA's Hubbard tells Judiciary Committee hearing. Senate Health Committee will mark up Sen. Gregg's import bill July 21.